194 related articles for article (PubMed ID: 16091292)
1. Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection.
Cinque P; Bestetti A; Marenzi R; Sala S; Gisslen M; Hagberg L; Price RW
J Neuroimmunol; 2005 Nov; 168(1-2):154-63. PubMed ID: 16091292
[TBL] [Abstract][Full Text] [Related]
2. CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy.
Valle M; Price RW; Nilsson A; Heyes M; Verotta D
Brain; 2004 May; 127(Pt 5):1047-60. PubMed ID: 15013955
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid levels of chemokines in HIV infected patients with and without opportunistic infection of the central nervous system.
Christo PP; Vilela Mde C; Bretas TL; Domingues RB; Greco DB; Livramento JA; Teixeira AL
J Neurol Sci; 2009 Dec; 287(1-2):79-83. PubMed ID: 19782379
[TBL] [Abstract][Full Text] [Related]
4. Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure.
Spudich S; Lollo N; Liegler T; Deeks SG; Price RW
J Infect Dis; 2006 Dec; 194(12):1686-96. PubMed ID: 17109340
[TBL] [Abstract][Full Text] [Related]
5. The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations.
Cinque P; Nebuloni M; Santovito ML; Price RW; Gisslen M; Hagberg L; Bestetti A; Vago G; Lazzarin A; Blasi F; Sidenius N
Ann Neurol; 2004 May; 55(5):687-94. PubMed ID: 15122709
[TBL] [Abstract][Full Text] [Related]
6. Chemokines CXCL10 and CXCL11 in the cerebrospinal fluid of patients with tick-borne encephalitis.
Lepej SZ; Misić-Majerus L; Jeren T; Rode OD; Remenar A; Sporec V; Vince A
Acta Neurol Scand; 2007 Feb; 115(2):109-14. PubMed ID: 17212614
[TBL] [Abstract][Full Text] [Related]
7. Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy.
Gisolf EH; van Praag RM; Jurriaans S; Portegies P; Goudsmit J; Danner SA; Lange JM; Prins JM
J Acquir Immune Defic Syndr; 2000 Dec; 25(5):426-33. PubMed ID: 11141242
[TBL] [Abstract][Full Text] [Related]
8. Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis.
Moreira MA; Tilbery CP; Monteiro LP; Teixeira MM; Teixeira AL
Acta Neurol Scand; 2006 Aug; 114(2):109-13. PubMed ID: 16867033
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and virological correlation between the cerebrospinal fluid and blood of HIV-infected children].
Sáez-Llorens X; Castrejón de Wong MC; Castaño E; de Suman O; Báez de Ulloa C; Redondo W; Espino M
Rev Med Panama; 2001; 26():13-8. PubMed ID: 16161718
[TBL] [Abstract][Full Text] [Related]
10. [Clinical importance of the quantification of HIV-1 RNA in cerebrospinal fluid for the diagnosis of HIV encephalitis].
Bossi P; Dupré S; Dupin N; Coutellier A; Bricaire F; Lubetzki C; Katlama C; Calvez V
Pathol Biol (Paris); 1998 Jun; 46(6):423-5. PubMed ID: 9769875
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma.
Monteiro de Almeida S; Letendre S; Zimmerman J; Lazzaretto D; McCutchan A; Ellis R
J Neuroimmunol; 2005 Dec; 169(1-2):144-52. PubMed ID: 16182380
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection.
Mellgren A; Price RW; Hagberg L; Rosengren L; Brew BJ; Gisslén M
Neurology; 2007 Oct; 69(15):1536-41. PubMed ID: 17923616
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of cerebrospinal fluid: potential for the study of HIV-1 infection of the central nervous system.
Cinque P; Bestetti A; Morelli P; Presi S
J Neurovirol; 2000 May; 6 Suppl 1():S95-S102. PubMed ID: 10871772
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatment.
Mellgren A; Antinori A; Cinque P; Price RW; Eggers C; Hagberg L; Gisslén M
Antivir Ther; 2005; 10(6):701-7. PubMed ID: 16218168
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.
Galimberti D; Schoonenboom N; Scheltens P; Fenoglio C; Bouwman F; Venturelli E; Guidi I; Blankenstein MA; Bresolin N; Scarpini E
Arch Neurol; 2006 Apr; 63(4):538-43. PubMed ID: 16606766
[TBL] [Abstract][Full Text] [Related]
16. Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy.
Edén A; Price RW; Spudich S; Fuchs D; Hagberg L; Gisslén M
J Infect Dis; 2007 Dec; 196(12):1779-83. PubMed ID: 18190258
[TBL] [Abstract][Full Text] [Related]
17. Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis.
Wang SM; Lei HY; Yu CK; Wang JR; Su IJ; Liu CC
J Infect Dis; 2008 Oct; 198(7):1002-6. PubMed ID: 18710325
[TBL] [Abstract][Full Text] [Related]
18. Viral load determines the B-cell response in the cerebrospinal fluid during human immunodeficiency virus infection.
Cepok S; von Geldern G; Nolting T; Grummel V; Srivastava R; Zhou D; Hartung HP; Adams O; Arendt G; Hemmer B
Ann Neurol; 2007 Nov; 62(5):458-67. PubMed ID: 17703460
[TBL] [Abstract][Full Text] [Related]
19. Concentration gradient of CXCL10 and CXCL11 between the cerebrospinal fluid and plasma in children with enteroviral aseptic meningitis.
Cavčić A; Tešović G; Gorenec L; Grgić I; Benić B; Lepej SŽ
Eur J Paediatr Neurol; 2011 Nov; 15(6):502-7. PubMed ID: 21703889
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection.
Brew BJ; Bhalla RB; Paul M; Gallardo H; McArthur JC; Schwartz MK; Price RW
Ann Neurol; 1990 Oct; 28(4):556-60. PubMed ID: 2252366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]